Targeting HER2 in Colorectal Cancer

April 11, 2017
Manish A. Shah, MD

Manish A. Shah, MD, discusses the HERACLES clinical trial, which explored treatment with trastuzumab (Herceptin) and lapatinib (Tykerb) in patients with HER2-amplified metastatic colorectal cancer.